脑部放疗，上午比下午敏感许多！
3 G( Q8 \7 t! i- d. |; `4 V# A0 N+ \) f7 a0 n
4 L+ Z9 {1 |& s
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.2 {& p$ n/ N% a( f6 N
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?8 ?. s( _3 ^+ j7 I
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
2 X, Y- [* c1 \, JSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.: k2 J" W0 U! N
% f2 Y/ {6 m: b; ?4 {9 \Abstract
' K Y; ^* y- {# s' zBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.! U, K. M: `+ l; T( g
$ f5 }+ }0 [. a' f8 o/ U) h
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.& k6 D- \! S# j4 q' s. F: h. ^ Q
" D$ y. l/ S- Q9 b8 `
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). l& s- F, T0 S# _- s
4 a. x0 M8 e6 |+ ~, B
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.5 Q% ], f' j/ R) h1 V9 K" ?
5 \$ D& v" c _7 f' ~' u
|
3 i" F3 N9 t& Y& r7 f- S: _
显身卡
